Health Care/Hospital
Dimora Medical Reaffirms Long-Term Commitment to Pressure Injury Patients on Worldwide Pressure Injury Prevention Day
NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Observed annually on the third Thursday of November each year, Worldwide Pressure Injury Prevention Day serves as a global reminder of the urgent need to prevent pressure injuries, also known as pressure ulcers or bedsores, among vulnerable populations. Est...
Colebrook Bosson Saunders Launches Their First Sustainability Report
HONG KONG, Nov. 21, 2025 /PRNewswire/ -- As the world turns its attention to
the environment duringCOP30, Colebrook Bosson Saunders (CBS),
PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting
IRVINE, Calif., Nov. 20, 2025 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotechnology company developing novel therapies for relapsed and refractory (r/r) B-cell malignancies, announced that two abstracts from its ongoing Phase 1 studies of PMB-CT01 (BAFFR-CAR T) have been accepted fo...
HitGen Receives New Funding to Discover Novel Therapeutics for Underserved Diseases
* Company enters into new agreement with the Gates Foundation to identify novel drug leads targeting tuberculosis and malaria and new agents for non-hormonal contraception. CHENGDU, China, Nov. 20, 2025 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH...
ReviR Therapeutics Receives $4.6 Million CIRM Grant to Advance Huntington's Disease Treatment and Announces Key Development Milestone
BRISBANE, Calif., Nov. 20, 2025 /PRNewswire/ -- ReviR Therapeutics, a biotech
company focused on developing innovative treatments for neurogenetic diseases,
announced today that it has been awarded a$4.6M grant from the California
Institute for Regenerative Medicine (CIRM)
GENPRIME ACCELERATES GLOBAL GROWTH WITH FERTILITY CENTRE LAUNCHES IN SINGAPORE AND MANILA
The Singapore and New York-headquartered network of clinics expands its Southeast Asia presence, addressing global family-building challenges with technology and empathy NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Rhea Fertility, the reproductive health platform headquartered inSingapore and New Yor...
Kolmar Korea Named Among TIME's World's Best Companies in Sustainable Growth 2026 for the Second Consecutive Year
Ranked in the Top 7% Among More Than 4,000 Global Corporations, Highlighting
Leadership in Eco-Friendly Innovation and Responsible Growth
SEOUL, South Korea, Nov. 20, 2025 /PRNewswire/ -- Kolmar Korea
Henlius' Serplulimab (anti-PD-1 mAb) Granted Breakthrough Therapy Designation by China NMPA for Neo-/Adjuvant Treatment for Gastric Cancer
* The first CDE-designated Breakthrough Therapy for perioperative gastric cancer, promising accelerated patient access. * The world's first gastric cancer perioperative regimen replacing chemotherapy with immunotherapy alone in the adjuvant setting has met primary endpoints in its phase 3 cli...
Clarity Eye Centre Brings SILK™ Laser Eye Technology to Hong Kong
HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Clarity Eye Centre announced the arrival of Johnson & Johnson's next-generation SILK™ Laser Eye Technology, now available to patients inHong Kong. The clinic is the first in the city to widely offer the ELITA™ Femtosecond Laser, the advanced system that po...
Gong Yingying: The Next Era of AI Healthcare Requires Trust, Real-World Scenarios, and Universal Accessibility
KUALA LUMPUR, Malaysia, Nov. 20, 2025 /PRNewswire/ -- At the 2025 Fortune Innovation Forum inKuala Lumpur, global industry leaders and innovators gathered to explore the technologies transforming healthcare. Speaking at the featured roundtable "AI vs. MD," Ms. Gong Yingying, Founder and Chairwoma...
Smartee Deepens Its Strategy for Central Asia and Russia in 2025
SHANGHAI, Nov. 20, 2025 /PRNewswire/ -- Smartee Denti-Technology is reinforcing its international footprint with a focused strategy inCentral Asia and Russia for 2025, cementing its position as a global leader in clear aligner and digital orthodontic technologies. This year, Smartee showcased it...
Remplir™ Nerve Sparing Prostate Cancer Surgery Commercial Opportunity Gathers Momentum with ~100 Surgeries Now Performed with Multiple Surgeons Nationwide
Company to invest in further research to strengthen clinical evidence ahead of medium-term U.S. launch with no further FDA approvals needed * Adoption of Remplir™ among Australian urologists is accelerating, with ~100 surgeries conducted by surgeons nationwide. * This promising new applicatio...
Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research
DURHAM, N.C. and SEOUL, South Korea, Nov. 20, 2025 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and comprehensive laboratory services, today announced a collaborative initiative to accelerate innovation i...
Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs
SHANGHAI and HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune dis...
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the CRDMO Industry
WuXi AppTec sets new benchmarks in strategic execution and technological
advancement, further strengthening its ability to support innovators worldwide
as they deliver breakthrough medicines for patients.
SAN ANTONIO, Nov. 20, 2025 /PRNewswire/ -- Frost & Sullivan
USANA Named No. 1 Dietary Supplements Brand in the Philippines for the 7th Consecutive Year
Euromonitor Recognizes USANA Philippines as the Market Leader from 2019 to 2025 MANILA, Philippines, Nov. 20, 2025 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in health and wellness, has once again been recognized as the No. 1 dietary supplements brand inthe Philippines* by Eurom...
ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses
MELBOURNE, Australia and INDIANAPOLIS, Nov. 20, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces results from the ZIRCON-X study which finds that almost half of all patients imaged with TLX250-CDx (Zircaix®[1], 89Zr-DFO-girentuximab) PET/CT[2] wo...
Dimora Medical Supports HS Connect Empower Workshop to Promote Science-Based Care for Hidradenitis Suppurativa Patients
NEW YORK, Nov. 19, 2025 /PRNewswire/ -- Patient-centered nonprofit organization HS Connect recently hosted the Empower HS: Knowledge and Advocacy Workshop, an educational event designed to help individuals living with Hidradenitis Suppurativa (HS) and their caregivers gain the knowledge and confi...
NABR: CITES Standing Committee Issues Assessment of Long-Tailed Macaque Monkey Breeding Practices
WASHINGTON, Nov. 20, 2025 /PRNewswire/ -- The Standing Committee of CITES, an international body responsible for monitoring trade in animal species, announced the results of its review of animal breeding practices inCambodia, thankingCambodia for providing extensive data and relying on science. T...
BestQool Announces Up to 21% Off Red Light Therapy Devices on Amazon for Black Friday
NEW YORK, Nov. 19, 2025 /PRNewswire/ -- This Black Friday, BestQool
Week's Top Stories
Most Reposted
Tonik raises US$12M Pre-Series C to scale capital-efficient lending in the Philippines
[Picked up by 318 media titles]
2025-12-04 10:15Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem
[Picked up by 311 media titles]
2025-12-04 16:00Klook takes the lead among international travelers booking paid tours and activities in Japan
[Picked up by 309 media titles]
2025-12-04 13:12HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 301 media titles]
2025-12-09 13:31World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 297 media titles]
2025-12-03 09:00